Opko Health Inc (NASDAQ: OPK)’s stock price has increased by 12.15 compared to its previous closing price of 1.07. However, the company has seen a 29.03% increase in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-03-25 that OPKO Health (OPK) and Entera Bio announce robust pharmacokinetic results for the proprietary GLP-2 agonist developed by OPK Heath.
Is It Worth Investing in Opko Health Inc (NASDAQ: OPK) Right Now?
Company’s 36-month beta value is 1.80.Analysts have differing opinions on the stock, with 3 analysts rating it as a “buy,” 3 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for OPK is 327.73M, and currently, short sellers hold a 31.17% ratio of that floaft. The average trading volume of OPK on April 01, 2024 was 14.65M shares.
OPK’s Market Performance
OPK stock saw an increase of 29.03% in the past week, with a monthly gain of 21.77% and a quarterly increase of -24.05%. The volatility ratio for the week is 8.42%, and the volatility levels for the last 30 days are 5.81% for Opko Health Inc (OPK). The simple moving average for the past 20 days is 26.61% for OPK’s stock, with a -16.94% simple moving average for the past 200 days.
Analysts’ Opinion of OPK
Many brokerage firms have already submitted their reports for OPK stocks, with Barrington Research repeating the rating for OPK by listing it as a “Outperform.” The predicted price for OPK in the upcoming period, according to Barrington Research is $2 based on the research report published on June 29, 2023 of the previous year 2023.
H.C. Wainwright, on the other hand, stated in their research note that they expect to see OPK reach a price target of $3. The rating they have provided for OPK stocks is “Buy” according to the report published on December 15th, 2022.
OPK Trading at 22.29% from the 50-Day Moving Average
After a stumble in the market that brought OPK to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -46.43% of loss for the given period.
Volatility was left at 5.81%, however, over the last 30 days, the volatility rate increased by 8.42%, as shares surge +20.00% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +21.73% upper at present.
During the last 5 trading sessions, OPK rose by +29.03%, which changed the moving average for the period of 200-days by -22.08% in comparison to the 20-day moving average, which settled at $0.9578. In addition, Opko Health Inc saw -20.53% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at OPK starting from FROST PHILLIP MD ET AL, who purchase 500,000 shares at the price of $0.87 back on Mar 18 ’24. After this action, FROST PHILLIP MD ET AL now owns 210,968,225 shares of Opko Health Inc, valued at $437,100 using the latest closing price.
FROST PHILLIP MD ET AL, the CEO & Chairman of Opko Health Inc, purchase 500,000 shares at $0.89 during a trade that took place back on Mar 14 ’24, which means that FROST PHILLIP MD ET AL is holding 210,468,225 shares at $444,300 based on the most recent closing price.
Stock Fundamentals for OPK
Current profitability levels for the company are sitting at:
- -0.18 for the present operating margin
- 0.34 for the gross margin
The net margin for Opko Health Inc stands at -0.22. The total capital return value is set at -0.09. Equity return is now at value -12.80, with -9.04 for asset returns.
Based on Opko Health Inc (OPK), the company’s capital structure generated 0.16 points at debt to capital in total, while cash flow to debt ratio is standing at -0.11. The debt to equity ratio resting at 0.19. The interest coverage ratio of the stock is 3488.33.
Currently, EBITDA for the company is -52.76 million with net debt to EBITDA at -2.75. When we switch over and look at the enterprise to sales, we see a ratio of 1.24. The receivables turnover for the company is 6.63for trailing twelve months and the total asset turnover is 0.43. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.55.
Conclusion
In a nutshell, Opko Health Inc (OPK) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
